on 20 Apr 2021
Last Applicant/ Owned by
AEQUUS PHARMACEUTICALS INC.
2820 - 200 GRANVILLE STREETVANCOUVER
BRITISH COLUMBIA
CA
V6C1S4
Serial Number
1773833 filed on 23rd Mar 2016
Correspondent Address
SUITE 702 - 401 WEST GEORGIA STREETVANCOUVER
BRITISH COLUMBIA
CA
V6B5A1
Vienna Information
26 . 11 . 1
One line or one bandUne ligne ou une bande
26 . 11 . 12
Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 8
Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.
27 . 5 . 12
Letters crossed or barred by letters, numerals or a figurative elementLettres traversées ou barrées par des lettres, des chiffres ou un élément figuratif
Trademark usage description
pharmaceutical preparations for the relief of pain, ocular and interocular surgery, immunosuppressant, neurological disorders namely epilepsy, lennox- Read MoreCIPO Classification Code
Nice
1773833
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 14 on 24th Sep 2019 | Default Notice Sent |
Submitted for opposition 12 on 22nd Mar 2019 | Extension of Time |
Submitted for opposition 15 on 06th Sep 2018 | Correspondence Created |
Submitted for opposition 12 on 27th Feb 2018 | Extension of Time |
Submitted for opposition 15 on 09th Aug 2017 | Correspondence Created |
Submitted for opposition 22 on 13th Dec 2016 | Search Recorded |
Submitted for opposition 20 on 13th Dec 2016 | Examiner's First Report |
Submitted for opposition 31 on 29th Mar 2016 | Formalized |
Submitted for opposition 1 on 24th Mar 2016 | Created |
Submitted for opposition 30 on 23rd Mar 2016 | Filed |